192 related articles for article (PubMed ID: 29927924)
41. The Impact of Early Recurrence on Quality of Life after Cytoreduction with HIPEC.
Hinkle NM; Botta V; Sharpe JP; Dickson P; Deneve J; Munene G
Am Surg; 2017 Jun; 83(6):633-639. PubMed ID: 28637567
[TBL] [Abstract][Full Text] [Related]
42. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Milovanov V; Sardi A; Studeman K; Nieroda C; Sittig M; Gushchin V
Ann Surg Oncol; 2016 Jun; 23(6):1928-33. PubMed ID: 26714951
[TBL] [Abstract][Full Text] [Related]
43. Thrombin generation and rotational thromboelastometry in the healthy adult population.
Schneider T; Siegemund T; Siegemund R; Petros S
Hamostaseologie; 2015; 35(2):181-6. PubMed ID: 25529462
[TBL] [Abstract][Full Text] [Related]
44. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
[TBL] [Abstract][Full Text] [Related]
45. Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors.
Charrier T; Passot G; Peron J; Maurice C; Gocevska S; Quénet F; Eveno C; Pocard M; Goere D; Elias D; Ortega-Deballon P; Vaudoyer D; Cotte E; Glehen O
Ann Surg Oncol; 2016 Jul; 23(7):2315-22. PubMed ID: 26920385
[TBL] [Abstract][Full Text] [Related]
46. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584
[TBL] [Abstract][Full Text] [Related]
47. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
48. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.
Ahmed S; Stewart JH; Shen P; Votanopoulos KI; Levine EA
J Surg Oncol; 2014 Oct; 110(5):575-84. PubMed ID: 25164477
[TBL] [Abstract][Full Text] [Related]
49. Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies.
Olesiński T
Pol Przegl Chir; 2017 Dec; 89(6):31-36. PubMed ID: 29335392
[TBL] [Abstract][Full Text] [Related]
50. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.
Mehta S; Schwarz L; Spiliotis J; Hsieh MC; Akaishi EH; Goere D; Sugarbaker PH; Baratti D; Quenet F; Bartlett DL; Villeneuve L; Kepenekian V;
Eur J Surg Oncol; 2018 Nov; 44(11):1786-1792. PubMed ID: 29885982
[TBL] [Abstract][Full Text] [Related]
51. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.
Hinkle NM; MacDonald J; Sharpe JP; Dickson P; Deneve J; Munene G
Am J Surg; 2016 Sep; 212(3):413-8. PubMed ID: 27086201
[TBL] [Abstract][Full Text] [Related]
52. Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study.
Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech JJ
Ann Surg; 2016 Feb; 263(2):369-75. PubMed ID: 25915913
[TBL] [Abstract][Full Text] [Related]
53. A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sargant N; Roy A; Simpson S; Chandrakumaran K; Alves S; Coakes J; Bell J; Knight J; Wilson P; Mohamed F; Cecil T; Moran B
Transfus Med; 2016 Apr; 26(2):118-22. PubMed ID: 27030339
[TBL] [Abstract][Full Text] [Related]
54. Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (hipec), a single centre experience.
Vukadinovic V; Chiou JD; Morris DL
Eur J Surg Oncol; 2015 May; 41(5):702-6. PubMed ID: 25680953
[TBL] [Abstract][Full Text] [Related]
55. Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis.
Halkia E; Efstathiou E; Rogdakis A; Christakis C; Spiliotis J
J BUON; 2015 May; 20 Suppl 1():S60-3. PubMed ID: 26051334
[TBL] [Abstract][Full Text] [Related]
56. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
Bhagwandin SB; Naffouje S; Salti G
J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
[TBL] [Abstract][Full Text] [Related]
57. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
Wong JF; Tan GH; Wang W; Soo KC; Teo MC
World J Surg; 2015 Jun; 39(6):1578-83. PubMed ID: 25651962
[TBL] [Abstract][Full Text] [Related]
58. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
59. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
60. Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis.
Simkens GA; van Oudheusden TR; Luyer MD; Nienhuijs SW; Nieuwenhuijzen GA; Rutten HJ; de Hingh IH
Ann Surg Oncol; 2015 Aug; 22(8):2656-62. PubMed ID: 25515200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
